106 related articles for article (PubMed ID: 29174608)
1. Effect of surfactants and hydrophilic polymers on the stability of an antihypertensive drug candesartan cilexetil: Evaluation by HPLC.
Krishna MV; Sowhardhra M; Kumar MS; Madhavi G; Jadhav T; Thakkar D
Ann Pharm Fr; 2018 Jan; 76(1):32-43. PubMed ID: 29174608
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
Sezgin-Bayindir Z; Antep MN; Yuksel N
AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
[TBL] [Abstract][Full Text] [Related]
3. The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution media.
Hoppe K; Sznitowska M
AAPS PharmSciTech; 2014 Oct; 15(5):1116-25. PubMed ID: 24871550
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System.
de Campos DP; Silva-Barcellos NM; Lima RR; Savedra RML; Siqueira MF; Yoshida MI; da Nova Mussel W; de Souza J
AAPS PharmSciTech; 2018 Oct; 19(7):3019-3028. PubMed ID: 30062540
[TBL] [Abstract][Full Text] [Related]
6. Comparative Pharmaceutical Evaluation of Candesartan and Candesartan Cilexetil: Physicochemical Properties, In Vitro Dissolution and Ex Vivo In Vivo Studies.
Amer AM; Allam AN; Abdallah OY
AAPS PharmSciTech; 2018 Feb; 19(2):661-667. PubMed ID: 28948575
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis and transesterification reactions of candesartan cilexetil observed during the solid phase extraction procedure.
Ferreirós N; Dresen S; Alonso RM; Weinmann W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):134-8. PubMed ID: 17478126
[TBL] [Abstract][Full Text] [Related]
8. Candesartan cilexetil microemulsions for transdermal delivery: formulation, in-vitro skin permeation and stability assessment.
Malakar J; Basu A; Nayak AK
Curr Drug Deliv; 2014; 11(3):313-21. PubMed ID: 24893994
[TBL] [Abstract][Full Text] [Related]
9. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
10. Anodic adsorptive stripping voltammetry of the antihypertensive drug candesartan cilexetil at a glassy carbon electrode.
Dogan B; Uslu B; Ozkan SA
Pharmazie; 2004 Nov; 59(11):840-4. PubMed ID: 15587583
[TBL] [Abstract][Full Text] [Related]
11. Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.
Musko M; Sznitowska M
Acta Pharm; 2014 Dec; 64(4):463-74. PubMed ID: 25531786
[TBL] [Abstract][Full Text] [Related]
12. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
Mehta S; Shah RP; Priyadarshi R; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
[TBL] [Abstract][Full Text] [Related]
13. New supersaturating drug delivery system as strategy to improve apparent solubility of candesartan cilexetil in biorelevant medium.
Pinto JMO; Leão AF; Alves GF; Mendes C; França MT; Fernandes D; Stulzer HK
Pharm Dev Technol; 2020 Jan; 25(1):89-99. PubMed ID: 31583925
[TBL] [Abstract][Full Text] [Related]
14. DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODS USED-FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITY AND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTAN CILEXETIL 32 MG TABLETS.
Yuce M; Capan Y
Acta Pol Pharm; 2017 Mar; 74(2):357-367. PubMed ID: 29624240
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
[TBL] [Abstract][Full Text] [Related]
16. Stability-Indicating Liquid Chromatographic Methods with Photodiode Array Detection and Light Scattering Detection for Simultaneous Determination of Candesartan and Hydrochlorothiazide.
de Diego M; Godoy R; Mennickent S; Vergara C; Miranda D; Navarro P
J Chromatogr Sci; 2018 Feb; 56(2):99-107. PubMed ID: 29236956
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of valsartan by aqueous glycerol, polyethylene glycol and micellar solutions.
Mbah CJ
Pharmazie; 2006 Apr; 61(4):322-4. PubMed ID: 16649547
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
19. Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug.
Aly UF; Sarhan HA; Ali TFS; Sharkawy HAE
Drug Des Devel Ther; 2020; 14():1851-1865. PubMed ID: 32523332
[TBL] [Abstract][Full Text] [Related]
20. The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil.
Ertürk AS; Gürbüz MU; Tülü M
Pharm Dev Technol; 2017 Feb; 22(1):111-121. PubMed ID: 27484586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]